Universal flu jab moves one step closer - paving way for end to yearly vaccinations

Long-sought universal flu vaccine: mRNA-based candidate enters clinical trial

The phase I trial will test safety and efficacy in a small number of people.

Trail for universal flu vaccine based on mRNA tech begins enrolling volunteers

Researchers for a universal flu vaccine based on mRNA technology are beginning to enroll volunteers in an early-stage clinical trial. The National Institute of Allergy and Infectious Diseases Vaccine Research Center has started to enroll volunteers at the Duke University for its Phase 1 trial of the mRNA-based vaccine, which uses the same technology as…

Feds Starts Enrolling Volunteers for mRNA Flu Vaccine Trial

Vaccine developers at the National Institute of Allergy and Infectious Diseases (NIAID) are enrolling healthy adult Americans to test an experimental universal influenza vaccine using mRNA technology. The Phase 1 trial will be conducted at Duke University in Durham, North Carolina, the NIAID said on Monday. Researchers will test the experimental vaccine, dubbed H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response. For thi…

Universal flu jab moves one step closer - paving way for end to yearly vaccinations

A new flu jab is being trialled that could protect against all strains of the virus - eliminating the need for seasonal vaccines and helping protect against potential future pandemics.

The NIH is enrolling volunteers in an early-stage trial for an mRNA-based universal flu vaccine

By Carma Hassan, CNN (CNN) — The National Institutes of Health is now enrolling participants to test an experimental universal influenza vaccine using mRNA technology. The NIH is looking for 50 volunteers ages 18 to 49 for the Phase 1 trial at Duke University in Durham, North Carolina. “A universal influenza vaccine would be a major public health achievement and could eliminate the need for both annual development of seasonal influenza vaccines,…

The NIH is enrolling volunteers in an early-stage trial for an mRNA-based universal flu vaccine

The National Institutes of Health is now enrolling participants to test an experimental universal influenza vaccine using mRNA technology.